Official UK procurement notice
2526-026-STA-WBS Provision of Altuvoct (Efanesoctocog alfa) recombinant FVII
Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (NHS & healthcare)
This note formally records that the Transparency Notice was not published at the required stage of the process, due to a procedural oversight. Once identified, the issue was promptly escalated and corrective action was taken to ensure a notice is completed and published in line with the relevant regulatory and governance requirements.
What is being bought
Published requirement descriptionThis note formally records that the Transparency Notice was not published at the required stage of the process, due to a procedural oversight. Once identified, the issue was promptly escalated and corrective action was taken to ensure a notice is completed and published in line with the relevant regulatory and governance requirements. Internal processes and controls have since been reviewed to reduce the risk of this happening again. This medicine is a NICE approved product which is not currently available for procurement under the Bleeding Disorders Framework, managed by NHS England. In order for Welsh patients to obtain access to this medicine while a contract is being negotiated between the supplier and NHS England, this contract is being direct awarded to SOBI.
Open work like this
This notice no longer takes bids · live search, filters set
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Sobi (Swedish Orphan Biovitrum Ltd)SMEProvision of Altuvoct (Efanesoctocog alfa) recombinant FVII27 Oct 2026 – 17 Aug 2028 | £270,000 | 14 Oct 2026standstill to 23 Oct 2026 | Standstill |
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 30 Sept 2026, 09:45 BST
- Last source update
- 14 Oct 2026, 11:29 BST
- FTS notice number
2026/S 000-096904- Latest notice
- Contract award notice (UK6)
- Delivery area
- Official registry OCID
ocds-h6vhtk-077d18Find a Tender
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
Sole supplier of the medicines required and purchase is critical for patient treatment.
How it was run
Official notice- Submission deadline
- —
Timeline
14 Oct 2026 → 23 Oct 2026 · 2 dates- Notice published39 days ago14 Oct 2026, 11:29 BST
- Standstill ends29 days ago23 Oct 2026, 23:59 BST
Notice history
3 events · 2 releases on Find a Tender · since 30 Sept 2026- Transparency notice published30 Sept 2026, 09:45 BSTUK5
- Contract award notice published14 Oct 2026, 11:29 BSTUK6
- Contract signature expected27 Oct 2026, 23:59 GMTscheduled
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Swedish Orphan Biovitrum (SOBI)Awarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedNotices published for this procedure
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender